At a glance
ClinicalIndex Comparison RecordN/ACompleted· 33,100 enrolled
Drug / intervention
Exposure to telemedicine, after the onset of the pandemicother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluating the Comparative Effectiveness of Telemedicine in Primary Care: Learning From the COVID-19 Pandemic
In Brief
An observational study evaluating Exposure to telemedicine, after the onset of the pandemic for Asthma and 4 related conditions. Completed, enrolled 33,100 participants across 4 sites.
Detailed Summary
Leveraging a natural experiment approach, the investigators will examine rapidly changing telemedicine and in-person models of care during and after the COVID-19 crisis to determine whether certain patients could safely choose to continue telemedicine or telemedicine-supplemented care, rather than return to in-person care.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma, Chronic Obstructive Pulmonary Disease (COPD), Congestive Heart Failure, Diabetes, Hypertension
CountriesUnited States
CollaboratorsPatient-Centered Outcomes Research Institute
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedDec 2020
Enrollment StartMar 2021
Primary CompletionApr 2022
TodayJul 2026
First PostedDec 28, 2020
Enrollment StartMar 15, 2021
Primary CompletionApr 1, 2022
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 5.5 years ago
Interventions
Exposure to telemedicine, after the onset of the pandemicother
The exposure of interest was the switch to primary care telemedicine prompted by the COVID-19 epidemic